北京福元医药股份有限公司
🇨🇳China
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
96
NMPA:96
Drug Approvals
Rosuvastatin Calcium and Ezetimibe Tablets (I)
- Product Name
- 瑞舒伐他汀依折麦布片(Ⅰ)
- Approval Number
- 国药准字H20253967
- Approval Date
- Apr 22, 2025
NMPA
Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ）
- Product Name
- 依折麦布阿托伐他汀钙片(Ⅱ)
- Approval Number
- 国药准字H20253380
- Approval Date
- Feb 11, 2025
NMPA
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets（III）
- Product Name
- 达格列净二甲双胍缓释片(Ⅲ)
- Approval Number
- 国药准字H20253200
- Approval Date
- Jan 14, 2025
NMPA
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets（I）
- Product Name
- 达格列净二甲双胍缓释片(Ⅰ)
- Approval Number
- 国药准字H20253160
- Approval Date
- Jan 14, 2025
NMPA
Mesalazine Enteric-coated Sustained-release Capsules
- Product Name
- 美沙拉嗪肠溶缓释胶囊
- Approval Number
- 国药准字H20249598
- Approval Date
- Dec 1, 2024
NMPA
Rupatadine Fumarate Tablets
- Product Name
- 富马酸卢帕他定片
- Approval Number
- 国药准字H20249437
- Approval Date
- Nov 22, 2024
NMPA
Azithromycin Dispersible Tablets
- Product Name
- 阿奇霉素分散片
- Approval Number
- 国药准字H19990396
- Approval Date
- Nov 20, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found